News | May 03, 2011

Mammography Detects Smaller Breast Tumors in Women Under Age 50

May 3, 2011 – Screening mammography benefits women between 40 and 49 years of age, and excluding this population from annual exams under the revised Preventative Service Task Force (USPSTF) mammography guidelines would negatively impact survival. The announcement is according to research presented at the American Society of Breast Surgeons Annual Meeting.

A 10-year retrospective study conducted at the University of Missouri in Columbia, Mo., found that mammography detected smaller tumors with less nodal metastasis than identified through clinical (manual) breast exams among women in this age group. 

“Breast cancer has a better prognosis when treated before tumors become palpable and identifiable through a physician or self-breast exam,” said researcher Paul Dale, M.D., chief of surgical oncology, Ellis Fischel Cancer Center at the University of Missouri School of Medicine. “The study also found mammographically detected patients also had better outcomes.”

The study looked at 1581 breast cancer patients treated between 1998 and 2008. Twenty percent of patients were between the ages of 40 and 49. Forty-seven percent of patients were diagnosed through mammography and 53 percent through clinical exams or other non-mammographic methods. In the mammography group, the mean tumor size was 20 mm in diameter, while non-mammographically identified tumors were 30 mm. The study also found that the frequency of lymph node involvement in the clinically detected groups was about twice that of mammographically detected patients.

Five year disease-free survival rate was estimated statistically through survival analysis methodology at 94 percent for mammography group and 78 percent for those identified clinically. Node negativity and tumor size were significantly associated with an increase in survival.

“We found that 20 percent of breast cancer patients in our institution are under age 50, and almost half of their tumors were detected through mammography,” Dale said. “Given recent advances in targeted treatment of early stage cancer, under these new guidelines, younger breast cancer patients not undergoing screening and early detection may miss out on important therapy that could significantly impact their survival.”

For more information: www.breastsurgeons.org

Related Content

Bay Labs Announces New Echocardiography Guidance Software Data at ASE 2019 Scientific Sessions
News | Cardiovascular Ultrasound | June 20, 2019
Bay Labs announced that new data on the company’s first-of-its-kind deep learning investigational guidance software...
LVivo EF Comparable to MRI, Contrast Echo in Assessing Ejection Fraction
News | Cardiovascular Ultrasound | June 19, 2019
DiA Imaging Analysis announced the presentation of two studies assessing the performance and accuracy of the company's...
New Data Demonstrates Safety Profile of GammaTile Therapy for Various Brain Tumors
News | Brachytherapy Systems | June 18, 2019
GT Medical Technologies Inc. announced the presentation of clinical data from a prospective study of GammaTile Therapy...
Black Men Less Likely to Adopt Active Surveillance for Low-Risk Prostate Cancer
News | Prostate Cancer | June 17, 2019
A new study reveals black men are less likely than white men to adopt an active surveillance strategy for their...
Fujifilm Announces Nationwide Breast Health Campaign With Mobile Mammography Coach

At the center of the campaign, Fujifilm will be traveling around the U.S. with its "Aspire to Be Fearless" mobile mammography coach to provide educational opportunities for clinicians, raise awareness about the importance of screening and will be providing mammograms to the underserved population in key locations.

News | Mammography | June 14, 2019
Fujifilm Medical Systems U.S.A. Inc. announced a nationwide awareness campaign titled ‘Aspire to Be Fearless’ focused...
Ikonopedia Showcases Risk Assessment and Resolution Manager Tools at SIIM and AHRA
News | Mammography Reporting Software | June 13, 2019
Ikonopedia will showcase its suite of structured breast reporting and Mammography Quality Standards Act (MQSA)...
iCAD Introduces ProFound AI for 2D Mammography in Europe
News | Artificial Intelligence | June 13, 2019
iCAD Inc. announced the launch of ProFound AI for 2D Mammography in Europe. This software is the latest addition to...
Three Palm Software Releases WorkstationOne Version 1.8.8
Technology | Mammography Reporting Software | June 12, 2019
Three Palm Software announced the release of the 1.8.8 version of its breast imaging workstation, WorkstationOne. This...
Volpara Health Technologies to Acquire MRS Systems Inc.
News | Mammography Reporting Software | June 04, 2019
Volpara Health Technologies, Volpara Solutions' parent company, has signed a binding agreement to acquire U.S.-based...
AI Biomarker Demonstrates High Predictive Power for Lung Cancer Immunotherapy
News | Artificial Intelligence | May 31, 2019
Lunit announced an abstract presentation of its artificial intelligence (AI) precision medicine research portfolio at...